YSPSL

DRUG3 trials

Sponsors

Y's Therapeutics, Inc.

Conditions

Delayed Graft FunctionKidney DiseasesLiver Diseases

Phase 1

YSPSL for Prevention of Delayed Graft Function Part B

CompletedNCT00298168

Y's Therapeutics, Inc.Kidney Diseases

Start: 2006-05-31End: 2007-12-31Updated: 2008-01-29

Phase 2

YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation

Y's Therapeutics, Inc.Liver Diseases

Start: 2007-03-31End: 2008-02-29Target: 12Updated: 2008-01-29

Unknown Phase

YSPSL for Prevention of Delayed Graft Function Part A

CompletedNCT00298181

Y's Therapeutics, Inc.Delayed Graft Function

Start: 2005-10-31End: 2007-12-31Updated: 2008-01-29

Related Papers

Immune Checkpoints are Important Therapeutic Targets in Cancer Immunotherapy

Cancer Science & Research2021-12-30